3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Osteosarcoma
2
Wilms Tumor
1
Sarcoma, Myeloid
1
Sarcoma, Clear Cell
1
Rhabdoid Tumor
1
Retinoblastoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Biphenotypic, Acute
1
Hepatoblastoma
1
Desmoplastic Small Round Cell Tumor
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Bone Neoplasms
1
Interventions
Cyclophosphamide
23
Temozolomide
14
Filgrastim
13
Irinotecan
12
Melphalan
11
Etoposide
10
Carboplatin
9
Vincristine
8
Peripheral Blood Stem Cell Transplantation
8
Granulocyte Colony-Stimulating Factor
8
X-Rays
7
Topotecan
7
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Busulfan
7
fludarabine
6
Thiotepa
6
Phantoms, Imaging
6
fludarabine phosphate
5
Radiotherapy
5
Biopsy
5
Antilymphocyte Serum
5
Oxaliplatin
4
Nuclear Medicine Department, Hospital
4
Nivolumab
4
Methylprednisolone
4
Ifosfamide
4
Cisplatin
4
palbociclib
3
olaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroblastoma
×
pegylated granulocyte colony-stimulating factor
×
Sarcoma
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled